Brain Tumor Res Treat.  2022 Jul;10(3):135-143. 10.14791/btrt.2022.0010.

Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments

• Ahn J
• Shin C
• Kim YS
• Park JS
• Jeun SS
• Ahn S

• KMID: 2532243
• DOI: http://doi.org/10.14791/btrt.2022.0010

Abstract

Over the last two decades, numerous studies have investigated the presence of human cytomegalovirus (CMV) within glioblastoma or gliomas; however, the results are severely conflicting. While a few researchers have suggested the potential benefits of cytotoxic T lymphocyte or dendritic cell-based vaccines for recurrent or newly diagnosed glioblastoma patients, several studies did not at all agree with the existence of CMV in glioblastoma cells. In this review, we summarized the conflicting results and issues about the detection of CMV in glioblastoma or glioma patients. We also provided the clinical data of published and unpublished clinical trials using CMV-specific immunotherapy for glioblastomas.

Keyword

Glioblastoma; Cytomegalovirus; Immunotherapy; Adoptive cell transfer; Cancer vaccines

Reference

1. Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol. 2005; 18:838–843. PMID: 15578071.

2. Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR. Lack of association of herpesviruses with brain tumors. J Neurovirol. 2006; 12:90–99. PMID: 16798670.

3. Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J, et al. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol. 2013; 87:8916–8926. PMID: 23740984.

4. Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun. 2013; 4:2513. PMID: 24085110.

5. Cimino PJ, Zhao G, Wang D, Sehn JK, Lewis JS Jr, Duncavage EJ. Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data. Exp Mol Pathol. 2014; 96:310–315. PMID: 24704430.

6. Cosset É, Petty TJ, Dutoit V, Cordey S, Padioleau I, Otten-Hernandez P, et al. Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response. Int J Cancer. 2014; 135:1381–1389. PMID: 24347514.

7. Solomon IH, Ramkissoon SH, Milner DA Jr, Folkerth RD. Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment. J Neuropathol Exp Neurol. 2014; 73:994–998. PMID: 25289896.

8. Lin CT, Leibovitch EC, Almira-Suarez MI, Jacobson S. Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls. Infect Agent Cancer. 2016; 11:32. PMID: 27462365.

9. Strong MJ, Blanchard E 4th, Lin Z, Morris CA, Baddoo M, Taylor CM, et al. A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association. Acta Neuropathol Commun. 2016; 4:71. PMID: 27402152.

10. Taha MS, Abdalhamid BA, El-Badawy SA, Sorour YM, Almsned FM, Al-Abbadi MA. Expression of cytomegalovirus in glioblastoma multiforme: myth or reality? Br J Neurosurg. 2016; 30:307–312. PMID: 26742571.

11. Johnson TS, Abrams ZB, Mo X, Zhang Y, Huang K. Lack of human cytomegalovirus expression in single cells from glioblastoma tumors and cell lines. J Neurovirol. 2017; 23:671–678. PMID: 28695489.

12. Strojnik T, Duh D, Lah TT. Prevalence of neurotropic viruses in malignant glioma and their onco-modulatory potential. In Vivo. 2017; 31:221–229. PMID: 28358704.

13. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002; 62:3347–3350. PMID: 12067971.

14. Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol. 2008; 10:10–18. PMID: 17951512.

15. Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, et al. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012; 14:246–255. PMID: 22319219.

16. Cobbs CS, Matlaf L, Harkins LE. Methods for the detection of cytomegalovirus in glioblastoma cells and tissues. Methods Mol Biol. 2014; 1119:165–196. PMID: 24639224.

17. Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Trémoulet M, et al. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer. 2005; 92:747–750. PMID: 15700045.

18. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 2008; 116:79–86. PMID: 18351367.

19. Ding D, Han S, Wang Z, Guo Z, Wu A. Does the existence of HCMV components predict poor prognosis in glioma? J Neurooncol. 2014; 116:515–522. PMID: 24395349.

20. Libard S, Popova SN, Amini RM, Kärjä V, Pietiläinen T, Hämäläinen KM, et al. Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS One. 2014; 9:e108861. PMID: 25268364.

21. Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A, et al. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signa. 2010; 3:ra58.

22. Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol. 2011; 103:231–238. PMID: 20820869.

23. Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, et al. Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother. 2012; 35:159–168. PMID: 22306904.

24. Rahbar A, Stragliotto G, Orrego A, Peredo I, Taher C, Willems J, et al. Low levels of human cytomegalovirus infection in glioblastoma multiforme associates with patient survival; -a case-control study. Herpesviridae. 2012; 3:3. PMID: 22424569.

25. Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Strååt K, et al. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol. 2013; 57:36–42. PMID: 23391370.

26. Baumgarten P, Michaelis M, Rothweiler F, Starzetz T, Rabenau HF, Berger A, et al. Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics. Neuro Oncol. 2014; 16:1469–1477. PMID: 25155358.

27. Yamashita Y, Ito Y, Isomura H, Takemura N, Okamoto A, Motomura K, et al. Lack of presence of the human cytomegalovirus in human glioblastoma. Mod Pathol. 2014; 27:922–929. PMID: 24336154.

28. Bianchi E, Roncarati P, Hougrand O, Guérin-El Khourouj V, Boreux R, Kroonen J, et al. Human cytomegalovirus and primary intracranial tumours: frequency of tumour infection and lack of correlation with systemic immune anti-viral responses. Neuropathol Appl Neurobiol. 2015; 41:e29–e40. PMID: 25041908.

29. Huang R, Qian D, Hu M, Zhang X, Song J, Li L, et al. Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma. Oncol Lett. 2015; 10:2812–2820. PMID: 26722247.

30. Shamran HA, Kadhim HS, Hussain AR, Kareem A, Taub DD, Price RL, et al. Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients. Biomed Res Int. 2015; 2015:642652. PMID: 25710012.

31. Stangherlin LM, Castro FL, Medeiros RS, Guerra JM, Kimura LM, Shirata NK, et al. Human cytomegalovirus DNA quantification and gene expression in gliomas of different grades. PLoS One. 2016; 11:e0159604. PMID: 27458810.

32. Xing Y, Wang Y, Wang S, Wang X, Fan D, Zhou D, et al. Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression. Transl Res. 2016; 177:113–126. PMID: 27474433.

33. Han S, Deng J, Wang Z, Liu H, Cheng W, Wu A. Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case-control study in Northern China. Cancer Immunol Immunother. 2017; 66:1265–1273. PMID: 28523518.

34. Hu M, Wang B, Qian D, Wang M, Huang R, Wei L, et al. Human cytomegalovirus immediate-early protein promotes survival of glioma cells through interacting and acetylating ATF5. Oncotarget. 2017; 8:32157–32170. PMID: 28473657.

35. Qin Z, Zhang L, Xu Y, Zhang X, Fang X, Qian D, et al. TLR3 regulates PD-L1 expression in human cytomegalovirus infected glioblastoma. Int J Clin Exp Pathol. 2018; 11:5318–5326. PMID: 31949612.

36. Maleki F, Sadigh ZA, Sadeghi F, Muhammadnejad A, Farahmand M, Parvin M, et al. Human cytomegalovirus infection in Iranian glioma patients correlates with aging and tumor aggressiveness. J Med Virol. 2020; 92:1266–1276. PMID: 31944314.

37. Tang KW, Hellstrand K, Larsson E. Absence of cytomegalovirus in high-coverage DNA sequencing of human glioblastoma multiforme. Int J Cancer. 2015; 136:977–981. PMID: 24961996.

38. Wakefield A, Pignata A, Ghazi A, Ashoori A, Hegde M, Landi D, et al. Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients. J Neurooncol. 2015; 125:307–315. PMID: 26341370.

39. Bahador M, Gras Navarro A, Rahman MA, Dominguez-Valentin M, Sarowar S, Ulvestad E, et al. Increased infiltration and tolerised antigen-specific CD8⁺ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV⁺ glioblastoma patients. Oncoimmunology. 2017; 6:e1336272. PMID: 28919997.

40. Garcia-Martinez A, Alenda C, Irles E, Ochoa E, Quintanar T, Rodriguez-Lescure A, et al. Lack of cytomegalovirus detection in human glioma. Virol J. 2017; 14:216. PMID: 29116009.

41. Holdhoff M, Guner G, Rodriguez FJ, Hicks JL, Zheng Q, Forman MS, et al. Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry, and in situ hybridization. Clin Cancer Res. 2017; 23:3150–3157. PMID: 28034905.

42. Yang CF, Ho HL, Lin SC, Hsu CY, Ho DM. Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects. PLoS One. 2017; 12:e0179366. PMID: 28594901.

43. Loit MP, Adle-Biassette H, Bouazza S, Mazeron MC, Manivet P, Lehmann-Che J, et al. Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples. J Neurovirol. 2019; 25:50–56. PMID: 30397828.

44. Limam S, Missaoui N, Hmissa S, Yacoubi MT, Krifa H, Mokni M, et al. Investigation of human cytomegalovirus and human papillomavirus in glioma. Cancer Invest. 2020; 38:394–405. PMID: 32643440.

45. Wen L, Zhao F, Qiu Y, Cheng S, Sun JY, Fang W, et al. Human cytomegalovirus DNA and immediate early protein 1/2 are highly associated with glioma and prognosis. Protein Cell. 2020; 11:525–533. PMID: 32189197.

46. Zavala-Vega S, Castro-Escarpulli G, Hernández-Santos H, Salinas-Lara C, Palma I, Mejía-Aranguré JM, et al. An overview of the infection of CMV, HSV 1/2 and EBV in Mexican patients with glioblastoma multiforme. Pathol Res Pract. 2017; 213:271–276. PMID: 28215646.

47. Bhattacharjee B, Renzette N, Kowalik TF. Genetic analysis of cytomegalovirus in malignant gliomas. J Virol. 2012; 86:6815–6824. PMID: 22496213.

48. Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF. Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J Virol. 2012; 86:854–864. PMID: 22090104.

49. Matlaf LA, Harkins LE, Bezrookove V, Cobbs CS, Soroceanu L. Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One. 2013; 8:e68176. PMID: 23861869.

50. dos Santos CJ, Stangherlin LM, Figueiredo EG, Corrêa C, Teixeira MJ, da Silva MC. High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients. J Med Virol. 2014; 86:1953–1961. PMID: 24173908.

51. Mohammad AA, Rahbar A, Lui WO, Davoudi B, Catrina A, Stragliotto G, et al. Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls. PLoS One. 2014; 9:e113740. PMID: 25462570.

52. Malekpour Afshar R, Mollaei HR, Zandi B, Iranpour M. Evaluation of JC and cytomegalo viruses in glioblastoma tissue. Asian Pac J Cancer Prev. 2016; 17:4907–4911. PMID: 28032494.

53. Adnan Ali SM, Mirza Y, Ahmad Z, Zahid N, Enam SA. Human papillomavirus and human cytomegalovirus infection and association with prognosis in patients with primary glioblastoma in Pakistan. World Neurosurg. 2019; 121:e931–e939. PMID: 30321676.

54. Goerig NL, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt MA, et al. Early mortality of brain cancer patients and its connection to cytomegalovirus reactivation during radiochemotherapy. Clin Cancer Res. 2020; 26:3259–3270. PMID: 32060103.

55. Ghaffari H, Tavakoli A, Faranoush M, Naderi A, Kiani SJ, Sadeghipour A, et al. Molecular investigation of human cytomegalovirus and Epstein-Barr virus in glioblastoma brain tumor: a case-control study in Iran. Iran Biomed J. 2021; 25:426–433. PMID: 34696577.

56. Yuan Z, Ye X, Zhu L, Zhang N, An Z, Zheng WJ. Virome assembly and annotation in brain tissue based on next-generation sequencing. Cancer Med. 2020; 9:6776–6790. PMID: 32738030.

57. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer. 2010; 10:878–889. PMID: 21102637.

58. Herbein G. The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses. 2018; 10:408.

59. El Baba R, Herbein G. Immune landscape of CMV infection in cancer patients: from “canonical” diseases toward virus-elicited oncomodulation. Front Immunol. 2021; 12:730765. PMID: 34566995.

60. Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009; 11:1–9. PMID: 19107226.

61. Rahman M, Dastmalchi F, Karachi A, Mitchell D. The role of CMV in glioblastoma and implications for immunotherapeutic strategies. Oncoimmunology. 2018; 8:e1514921. PMID: 30546954.

62. Schuessler A, Smith C, Beagley L, Boyle GM, Rehan S, Matthews K, et al. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. Cancer Res. 2014; 74:3466–3476. PMID: 24795429.

63. Smith C, Lineburg KE, Martins JP, Ambalathingal GR, Neller MA, Morrison B, et al. Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme. J Clin Invest. 2020; 130:6041–6053. PMID: 32750039.

64. Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, et al. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature. 2015; 519:366–369. PMID: 25762141.

65. Reap EA, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, et al. Dendritic cells enhance polyfunctionality of adoptively transferred T cells that target cytomegalovirus in glioblastoma. Cancer Res. 2018; 78:256–264. PMID: 29093005.

66. Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, et al. Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination. Clin Cancer Res. 2017; 23:1898–1909. PMID: 28411277.